Centre for Molecular Pharmacology | Faculty of Medicine and Health Sciences
| Compound | Retatrutide (CAS: 1355312-20-5) |
| Strength | 10 mg |
| Batch / Lot Number | RT-2024-03B |
| Date of Analysis | February 18, 2026 |
To access the full PDF report, please click the link below. By proceeding, you confirm you have read and agree to the terms of access.
Open Full Report (PDF)2.1 Confidentiality Statement: The data contained in the forthcoming document (hereafter "the Report") is considered confidential and proprietary to the Centre for Molecular Pharmacology (hereafter "the Centre"). The recipient of this data (hereafter "the User") agrees to hold the Report in strict confidence and not to disclose its contents to any third party without prior written authorization from the Centre.
2.2 Intended Use: The Report is provided for informational purposes only related to the specific batch number listed in section 1.3. The Centre makes no warranties, express or implied, regarding the use of this data for purposes other than analytical review.
2.3 Limitation of Liability: In no event shall McGill University or the Centre be liable for any damages arising from the User's reliance on the data provided in the Report. The User assumes all responsibility for the interpretation and application of said data.
2.4 Governing Law: This agreement shall be governed by and construed in accordance with the laws of the Province of Quebec.